Showing 101 - 120 results of 2,974 for search '"drug interaction"', query time: 0.22s Refine Results
  1. 101
  2. 102
  3. 103

    Development of TCM herb and anti-hypertensive drug interaction database by Yeow, Melissa Wei Bao

    Published 2014
    “…However, both the general public and healthcare professionals (HCPs) are poorly informed about TCM herb-drug interactions, and lack access to information about them. …”
    Get full text
    Final Year Project (FYP)
  4. 104

    The pharmacokinetics and drug-drug interactions of ivermectin in Aedes aegypti mosquitoes by Duthaler, U, Weber, M, Hofer, L, Chaccour, C, Maia, M, Müller, P, Krähenbühl, S, Hammann, F

    Published 2021
    “…Primary pharmacokinetic parameters and extent of drug-drug interactions were calculated by pharmacometric modelling. …”
    Journal article
  5. 105

    Checklist for standardized reporting of drug-drug interaction management guidelines by Floor-Schreudering, A, Geerts, A, Aronson, J, Bouvy, M, Ferner, R, De Smet, P

    Published 2014
    “…Purpose: Inconsistencies and omissions in drug-drug interaction (DDI) management guidelines may lead to harm and suboptimal therapy. …”
    Journal article
  6. 106
  7. 107

    Drug interactions between dolutegravir and artemether-lumefantrine or artesunate-amodiaquine by Walimbwa, S, Lamorde, M, Waitt, C, Kaboggoza, J, Else, L, Byakika-Kibwika, P, Amara, A, Gini, J, Winterberg, M, Chiong, J, Tarning, J, Khoo, S

    Published 2018
    “…We undertook two pharmacokinetic studies in healthy volunteers, using standard adult doses of artmether-lumefantrine or artesunate-amodiaquine given with 50mg once daily dolutegravir (DTG) to investigate the drug-drug interaction between artmether-lumefantrine or artesunate-amodiaquine and dolutegravir. …”
    Journal article
  8. 108

    Checklist for standardized reporting of drug-drug interaction management guidelines. by Floor-Schreudering, A, Geerts, A, Aronson, J, Bouvy, M, Ferner, R, De Smet, P

    Published 2014
    “…PURPOSE: Inconsistencies and omissions in drug-drug interaction (DDI) management guidelines may lead to harm and suboptimal therapy. …”
    Journal article
  9. 109

    Capsaicin: current understanding in therapeutic effects, drug interaction, and bioavailability by Chan, Suk Huei, Azlan, Azrina, Ismail, Amin, Shafie, Nurul Husna

    Published 2020
    “…Currently, capsaicin research, especially in drug interaction and encapsulation technologies, has not been reviewed. …”
    Get full text
    Article
  10. 110
  11. 111

    Case report: Drug-drug interaction between alectinib and apixaban in NSCLC by J.L. Gulikers, M. Slikkerveer, K. Winckers, L.E.L. Hendriks, S. Dursun, S. Croes, R.M.J.M. van Geel

    Published 2022-09-01
    “…Plasma concentrations of direct oral anticoagulants (DOAC) are potentially affected because of drug-drug interactions (DDI) with anticancer treatment as a result of inhibition or induction of CYP3A4, p-glycoprotein (P-gp) and/or Breast Cancer Resistance Protein (BCRP) interactions.Here, we present a 78-year-old patient with non-small cell lung cancer (NSCLC) receiving treatment with alectinib concurrent with apixaban as prophylactic treatment of recurrent thrombophlebitis. …”
    Get full text
    Article
  12. 112
  13. 113
  14. 114
  15. 115
  16. 116
  17. 117
  18. 118
  19. 119
  20. 120

    Management of clinical relevant drug-drug interactions with antipsychotics in nursing homes by Catarina Bernardo, João Pedro Aguiar, Filipa Alves da Costa

    Published 2021-04-01
    “…AbstractIntroduction Antipsychotics (APs) have been linked to several clinically relevant drug-drug interactions (leading, e.g. to QT-prolongation, torsades de pointes) but little is known about their management in nursing homes residents. …”
    Get full text
    Article